Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

Episode 18 December 17, 2021 00:13:40
Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam
The Botanicals Podcast
Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

Dec 17 2021 | 00:13:40

/

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

 

Other Episodes

Episode 0

December 11, 2020 00:25:41
Episode Cover

Hemp: 'An Economic Experiment on a Grand Scale'

JLN Editor Thom Thompson explains the twists and turns of the 2020 hemp market and looks ahead to 2021.

Listen

Episode 0

September 29, 2020 00:18:13
Episode Cover

Cannabis sector outperforms S&P 500 as U.S. sales grow

Saleem Daya, analyst at Nasdaq corporate solutions in Toronto, updates John Lothian News on the Q2 performance of listed cannabis shares amid strong U.S....

Listen

Episode 0

July 21, 2021 00:20:20
Episode Cover

Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on...

Listen